Retroreflective Janus Microparticle as a Nonspectroscopic Optical Immunosensing Probe
Source abstract
Abstract
We developed retroreflective Janus microparticles (RJPs) as a novel optical immunosensing probe for use in a nonspectroscopic retroreflection-based immunoassay. By coating the metals on the hemispherical surface of silica particles, highly reflective RJPs were fabricated. On the basis of the retroreflection principle, the RJPs responded to polychromatic white light sources, in contrast to conventional optical probes, which require specific monochromatic light. The retroreflection signals from RJPs were distinctively recognized as shining dots, which can be intuitively counted using a digital camera setup. Using the developed retroreflective immunosensing system, cardiac troponin I, a specific biomarker of acute myocardial infarction, was detected with high sensitivity. On the basis of the demonstrated features of the retroreflective immunosensing platform, we expect that our approach may be applied for various point-of-care-testing applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Biosensors and Analytical Detection · Advanced Biosensing Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Applied Chemistry & Biological Engineering and ‡Department of Molecular Science & Technology, Ajou University, Suwon 443749, South Korea
Funding
Samsung Research Funding Center of Samsung Electronics
References (36)
Show source-provided references
1. 10.1021/cr068105t10.1021/cr068105t ↗
2. 10.1039/b812343h10.1039/b812343h ↗
3. 10.1039/b300617d10.1039/b300617d ↗
4. 10.1016/j.drudis.2006.10.00310.1016/j.drudis.2006.10.003 ↗
5. 10.1002/lpor.20110002510.1002/lpor.201100025 ↗
6. 10.1039/C2LC40864C10.1039/C2LC40864C ↗
7. 10.1021/acs.analchem.5b0161210.1021/acs.analchem.5b01612 ↗
8. 10.1002/adma.20110185310.1002/adma.201101853 ↗
9. 10.1038/nmat216210.1038/nmat2162 ↗
10. 10.1021/cr200117810.1021/cr2001178 ↗
11. 10.1002/adma.20050078610.1002/adma.200500786 ↗
12. 10.1002/anie.20120574810.1002/anie.201205748 ↗
13. 10.1126/scitranslmed.300398110.1126/scitranslmed.3003981 ↗
14. 10.1021/ac800112r10.1021/ac800112r ↗
15. 10.2307/354316610.2307/3543166 ↗
16. 10.1364/AO.17.00185510.1364/AO.17.001855 ↗
17. 10.1088/0957-0233/10/7/40310.1088/0957-0233/10/7/403 ↗
18. 10.1088/0957-0233/14/6/40410.1088/0957-0233/14/6/404 ↗
19. 10.1364/AO.51.00374410.1364/AO.51.003744 ↗
20. 10.1088/1464-4258/11/8/08540410.1088/1464-4258/11/8/085404 ↗
21. 10.1021/ac501491t10.1021/ac501491t ↗
22. 10.1039/C2TC00350C10.1039/C2TC00350C ↗
23. 10.1021/am400314910.1021/am4003149 ↗
24. 10.1021/am506530s10.1021/am506530s ↗
25. 10.1016/j.bios.2011.02.03610.1016/j.bios.2011.02.036 ↗
26. 10.1016/j.clinbiochem.2009.01.01910.1016/j.clinbiochem.2009.01.019 ↗
27. 10.1016/j.snb.2012.05.07710.1016/j.snb.2012.05.077 ↗
28. 10.1016/0021-9797(68)90272-510.1016/0021-9797(68)90272-5 ↗
29. 10.1016/S0927-7765(98)00050-210.1016/S0927-7765(98)00050-2 ↗
30. 10.1166/jnn.2011.367610.1166/jnn.2011.3676 ↗
31. 10.1021/ph500423710.1021/ph5004237 ↗
32. 10.1364/JOSA.55.00120510.1364/JOSA.55.001205 ↗
33. 10.1364/AO.12.00055510.1364/AO.12.000555 ↗
34. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), 2005.
35. 10.1039/C0LC00204F10.1039/C0LC00204F ↗
36. 10.1021/ac101405a10.1021/ac101405a ↗